Pharmacokinetic Engineering of OX40-Blocking Anticalin Proteins Using Monomeric Plasma Half-Life Extension Domains
Martin Siegemund(University of Stuttgart), Christine Rothe
Cited by 11
Related Papers
Superior antitumoral activity of dimerized targeted single-chain TRAIL fusion proteins under retention of tumor selectivity
|Cell Death and Disease|2012|67